Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Fumikazu, Takeda"'
Autor:
Masaru, Narabayashi, Yasuo, Saijo, Seiichi, Takenoshita, Masayuki, Chida, Naohito, Shimoyama, Takeshi, Miura, Kazuhiko, Tani, Kousuke, Nishimura, Yusuke, Onozawa, Toyoshi, Hosokawa, Toshiyuki, Kamoto, Tomoyasu, Tsushima, Fumikazu, Takeda
Publikováno v:
Japanese Journal of Clinical Oncology. 38:296-304
Objective: We prospectively investigated the efficacy of opioid rotation from oral morphine to oral oxycodone in cancer patients who had difficulty in continuing oral morphine treatment because of inadequate analgesia and/or intolerable side effects.
Autor:
Fumikazu Takeda, Wasaburo Koizumi, Hiroyasu Hasegawa, Hiroya Takiuchi, Hideyuki Kimura, Hiroshi Toma, Kazuaki Hiraga, Ken Kodama, Kaoru Matsui, Ichiro Kono, Masaaki Kawahara, Nobuhito Araki, Kaoru Hatanaka, Ken-ichi Watanabe, Kunitoshi Yoshino, Kanji Katayama
Publikováno v:
Japanese Journal of Clinical Oncology. 34:608-614
Background: We conducted an open-label, dose titration study to assess the efficacy and tolerability of controlled-release oxycodone in the therapy of cancer pain management, starting with a newly developed 5 mg tablet every 12 h. Methods: Twenty-two
Autor:
Fumikazu Takeda
Publikováno v:
European Journal of Pain. 5:79-82
Japan's national cancer relief programme was initiated with a field-test of the WHO guidelines for cancer pain management in 1982. It revealed in an excellent result that 87% of 156 cancer patients could be completely relieved of their persistent pai
Autor:
Tadao Kakizoe, Fumikazu Takeda, Takashi Sugimura, Naohito Shimoyama, Eduardo Bruera, Jack C. Collins
Publikováno v:
Japanese Journal of Clinical Oncology. 31:459-468
The Fourteenth International Symposium of the Foundation for the Promotion of Cancer Research, entitled ‘Pain Control, Palliative Medicine and Psycho-oncology: Present Status and Future Direction’, was held in Tokyo on January 24–26, 2001. The
Autor:
Fumikazu Takeda
Publikováno v:
Ensho. 19:81-84
The indications for morphine in palliative cancer care are severe pain, dyspnea (tachypnea), cough and diarrhea. The use of morphine is the mainstay in managing cancer pain, because it is simple to administer and, when properly used, it is very effec
Publikováno v:
Journal of Pain and Symptom Management. 16:364-373
Despite recognition that pain management is an important component in the treatment of Japanese cancer patients, progress in this area has been slowed by the lack of an appropriate measure of pain. In a prospective, single-institution study, a Japane
Publikováno v:
Life Sciences. 64:PL1-PL7
We previously reported that the morphine-induced place preference was attenuated under inflammation produced by the unilateral injection of 2.5 % formalin (50 microl) into the hind paw of rats. In the present study, to elucidate the mechanism of this
Publikováno v:
Surgical Neurology. 50:475-479
Background Adenoid cystic carcinoma is a slow-growing malignant tumor occurring in the head and neck. Intracranial involvement usually results from direct skull invasion from adjacent primary sites. To our knowledge, this is the first reported case o
Publikováno v:
Journal of Nippon Medical School. 64:538-545
In this study, a new Questionnaire, "Care Note", was developed for palliative cancer care and it was validated in relation to the level of satisfaction in their daily lives felt by patients during supportive care. Care Note and EORTC QLQ-C 30 were ad
Autor:
Fumikazu Takeda
Publikováno v:
Nihon Naika Gakkai Zasshi. 85:2015-2020
がん患者の痛みは治療できる症状であり,治療すべき症状である.治療法の主役は鎮痛薬の使用であり,モルヒネが大きな役割を果たす.すべてのがん患者を痛みから解放すべく確立された安